Comment
doi: 10.1038/s41571-021-00490-4.
Advancing oncolytic virus therapy by understanding the biology
Affiliations
- PMID: 33686265
- DOI: 10.1038/s41571-021-00490-4
Item in Clipboard
Comment
Advancing oncolytic virus therapy by understanding the biology
Nat Rev Clin Oncol.
2021 Apr.
No abstract available
Comment on
-
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective.Cancer Cell. 2021 Mar 8;39(3):394-406.e4. doi: 10.1016/j.ccell.2020.12.022. Epub 2021 Jan 21. Cancer Cell. 2021. PMID: 33482123
Similar articles
-
Oncolytic Virotherapy by HSV.Adv Exp Med Biol. 2018;1045:63-84. doi: 10.1007/978-981-10-7230-7_4. Adv Exp Med Biol. 2018. PMID: 29896663 Review.
-
Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.Nanomedicine (Lond). 2020 Jan;15(1):93-110. doi: 10.2217/nnm-2019-0323. Nanomedicine (Lond). 2020. PMID: 31868115 Review.
-
Development of oncolytic virotherapy: from genetic modification to combination therapy.Front Med. 2020 Apr;14(2):160-184. doi: 10.1007/s11684-020-0750-4. Epub 2020 Mar 7. Front Med. 2020. PMID: 32146606 Free PMC article. Review.
-
Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.Curr Cancer Drug Targets. 2018;18(2):202-208. doi: 10.2174/1568009617666170222142650. Curr Cancer Drug Targets. 2018. PMID: 28228083 Review.
-
Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018.Curr Cancer Drug Targets. 2018;18(2):108. doi: 10.2174/156800961802180115100950. Curr Cancer Drug Targets. 2018. PMID: 29457568 No abstract available.
Cited by
-
Applications of Intravital Imaging in Cancer Immunotherapy.Bioengineering (Basel). 2024 Mar 8;11(3):264. doi: 10.3390/bioengineering11030264. Bioengineering (Basel). 2024. PMID: 38534538 Free PMC article. Review.
-
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery.Nat Mater. 2024 Dec;23(12):1736-1747. doi: 10.1038/s41563-024-01961-6. Epub 2024 Sep 2. Nat Mater. 2024. PMID: 39223270 Free PMC article.
-
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell.Adv Sci (Weinh). 2023 Aug;10(22):e2300121. doi: 10.1002/advs.202300121. Epub 2023 May 31. Adv Sci (Weinh). 2023. PMID: 37254712 Free PMC article. Review.
-
SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription.J Virol. 2024 Nov 19;98(11):e0104224. doi: 10.1128/jvi.01042-24. Epub 2024 Oct 7. J Virol. 2024. PMID: 39373477 Free PMC article.
-
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.Signal Transduct Target Ther. 2022 Sep 19;7(1):331. doi: 10.1038/s41392-022-01136-2. Signal Transduct Target Ther. 2022. PMID: 36123348 Free PMC article. Review.
References
-
- Kaufman, H. L. et al. Oncolytic viruses: a new class of immunotherapy. Nat. Rev. Drug Disc. 18, 642–662 (2015). - DOI
-
- Andtbacka, R. H. et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780–2788 (2015). - DOI
-
- Andtbacka, R. H. et al. Patterns of clinical response with Talimogene laherparepvec in patients with melanoma treated in the OPTiM Phase III clinical trial. Ann. Surg. Oncol. 23, 4169–4177 (2016). - DOI
-
- Kaufman, H. L. et al. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIC and IV melanoma. Ann. Surg. Oncol. 17, 718–730 (2010). - DOI
-
- Macedo, N. et al. Clinical landscape of oncolytic virus research in 2020. J. Immunother. Cancer. 8, e001486 (2020). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
